Document is current
Any future updates will be listed below
-
Authors
Zamir, Nasim
Pook, Makena
McDonald, Ellen
Fox-Robichaud, Alison E. https://orcid.org/0000-0001-9912-3606
-
Funding
Funding for this research was provided by:
ICU Medical Inc (N/A)
- License Information
-
More Information
Article History
Received: 29 July 2019
Accepted: 30 January 2020
First Online: 18 February 2020
Ethics approval and consent to participate
: HiREB granted approval for the conduct of this pilot trial (HIREB #3654) prior to patient enrolment. The trial is conducted in line with good clinical practice following Canadian tri-council guidelines. Any changes to the trial protocol must be communicated to, reviewed, and approved by HiREB. Any approved changes to the protocol will be disseminated to the research staff by the principal investigator. This protocol involves an informed consent process.
: Not applicable
: ICU Medical and ATTWILL do not have input into the design or implementation of this study or have access to study data until analysis is complete. ICU Medical was involved in training the bedside nursing staff on appropriate use of ChloraLock<sup>TM</sup>. AFR did not receive any personal financial compensation for conducting the trial.
